Tower Research Capital LLC (Trc) Edgewise Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 307 shares of EWTX stock, worth $9,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307
Previous 5,590
94.51%
Holding current value
$9,056
Previous $100,000
92.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EWTX
# of Institutions
192Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$443 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$263 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$177 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$172 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$164 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.86B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...